Mangoceuticals (MGRX) Other Operating Expenses (2023 - 2026)

Mangoceuticals has disclosed Other Operating Expenses across 4 years of filings, most recently posting $821160.0 for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 80.04% year-over-year to $821160.0; the TTM figure through Jun 2026 stood at $10.0 million (up 5.65% YoY), while the FY2025 annual figure was -$125624.0, down 102.35% from the prior year.
• Other Operating Expenses came in at $821160.0 for Q2 2026 at Mangoceuticals, down from $2.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $7.3 million in Q3 2025 to a low of -$241976.0 in Q4 2025.
• Average Other Operating Expenses over 4 years is $2.2 million, with a median of $1.8 million recorded in 2023.
• The largest YoY upside for Other Operating Expenses was 453.0% in 2025 against a maximum downside of 126.78% in 2025.
• Over 4 years, Other Operating Expenses stood at $1.9 million in 2023, then plunged by 52.13% to $903710.0 in 2024, then slumped by 126.78% to -$241976.0 in 2025, then soared by 439.36% to $821160.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $821160.0 in Q2 2026, $2.1 million in Q1 2026, and -$241976.0 in Q4 2025.